Company Performance: Profitability, revenue growth, and financial health directly impact investor confidence and stock valuation.

Market Sentiment: Overall investor mood, influenced by economic news and global events, affects buying and selling pressure.

Sector Trends: Performance of the pharmaceutical industry and biotechnology sector plays a key role.

Economic Conditions: Interest rates, inflation, and GDP growth influence investment decisions.

Regulatory Changes: New drug approvals, patent laws, and healthcare policies can significantly alter stock value.

Competition: Actions of rival pharmaceutical companies, including new drug launches, can affect market share.

News & Events: Company-specific announcements like clinical trial results and mergers drive price volatility.

Investor Relations: Effective communication with shareholders builds trust and supports valuation.

Global Events: Geopolitical instability and pandemics may significantly sway investor confidence in the stock.